María del Carmen Ruiz-Fuentes

TL;DR: Although patients who died presented with worse respiratory situation at admission, this was not significantly different at tocilizumab administration and did not have an impact on outcome in the multivariate analysis.

TL;DR: In this article, a multivariable analysis, age, pneumonia, and kidney transplant performed ≤6 months before COVID-19 were predictors of death, whereas gastrointestinal symptoms were protective.

TL;DR: In this paper, the authors presented a multicenter cohort study of 51 kidney transplant recipients with COVID-19 treated with remdesivir, which demonstrated antiviral activity against coronavirus, shortening the time to recovery in adults hospitalized with moderate/severe COVID19.

TL;DR: The mRNA-1273 vaccine shows higher clinical effectiveness than BNT162b2 in KT recipients with breakthrough infections and has remained high and has not improved despite receiving 2 doses of the mRNA vaccine.